The global market for smart medical devices is projected to grow from $87.7 billion in 2025 to reach $193.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.1% from 2025 through 2030.
Smart medical devices are designed as Internet of Things (IoT) healthcare solutions, embedded with sensors to gather, analyze and transmit patients’ information. These devices use Bluetooth, Wi-Fi and connectivity solutions to quickly forward information to patients and doctors. Including advanced sensors and connectivity enhances remote monitoring and continuous health tracking, improving patient outcomes and clinical decision making. The global smart medical devices market was valued at $75.9 billion in 2024 and is expected to reach $193.3 billion by the end of 2030. The market is expected to grow at a compound annual growth rate (CAGR) of 17.1% during the forecast period.
Smart healthcare dates back to the 20th century, beginning with the implantable pacemaker introduced in 1958 for arrhythmia patients. Smart medical devices include biomedical monitoring systems that support continuous measurement of critical biomarkers for diagnostics, physiological health tracking and disease management. These devices have become even more sophisticated and efficient through advances in electronics, biocompatible materials and nanotechnology. Integrating small sensors into biomedical devices without disruption is now possible, improving diagnostic and prognostic capabilities.
The report provides a comprehensive regional analysis covering North America, Europe, the Asia-Pacific region, South America, and the Middle East and Africa. It evaluates the market dynamics, including drivers, challenges and emerging trends, while highlighting product and performance enhancement innovations. The study concludes with an analysis of major market players and their offerings.
The report includes global revenue ($ millions) for the base year of 2024, estimates for 2025 and projections of compound annual growth rates (CAGRs) from 2025 through 2030.
Smart medical devices are designed as Internet of Things (IoT) healthcare solutions, embedded with sensors to gather, analyze and transmit patients’ information. These devices use Bluetooth, Wi-Fi and connectivity solutions to quickly forward information to patients and doctors. Including advanced sensors and connectivity enhances remote monitoring and continuous health tracking, improving patient outcomes and clinical decision making. The global smart medical devices market was valued at $75.9 billion in 2024 and is expected to reach $193.3 billion by the end of 2030. The market is expected to grow at a compound annual growth rate (CAGR) of 17.1% during the forecast period.
Smart healthcare dates back to the 20th century, beginning with the implantable pacemaker introduced in 1958 for arrhythmia patients. Smart medical devices include biomedical monitoring systems that support continuous measurement of critical biomarkers for diagnostics, physiological health tracking and disease management. These devices have become even more sophisticated and efficient through advances in electronics, biocompatible materials and nanotechnology. Integrating small sensors into biomedical devices without disruption is now possible, improving diagnostic and prognostic capabilities.
Report Scope
This report analyzes the global smart medical devices market and segments the market by product type, application and end user. The report also provides insights into key emerging trends and potential growth drivers. The study focuses on product types, including implantable, wearable and non-wearable medical devices, assessing their adoption across diverse applications that include cardiovascular, diabetes, neurology and sleep disorders.The report provides a comprehensive regional analysis covering North America, Europe, the Asia-Pacific region, South America, and the Middle East and Africa. It evaluates the market dynamics, including drivers, challenges and emerging trends, while highlighting product and performance enhancement innovations. The study concludes with an analysis of major market players and their offerings.
The report includes global revenue ($ millions) for the base year of 2024, estimates for 2025 and projections of compound annual growth rates (CAGRs) from 2025 through 2030.
The report includes:
- 103 data tables and 52 additional tables
- A review of the global market for smart medical devices
- Analyses of the global market trends, with sales data for 2022-2024, estimates for 2025, and projections of compound annual growth rates (CAGRs) through 2030
- Evaluation and forecast of the market for smart medical devices, and a corresponding market share analysis by product type, application, end user and region
- A look at emerging technological trends, and the opportunities and gaps in current and future demand for smart medical devices
- Coverage of the technological issues related to smart medical devices
- Identification of the companies best positioned to meet the demand for smart medical devices due to their proprietary technologies, new products, and strategic alliances
- Discussion of the industry value chain, the demand-supply gap, and factors driving the growth of the market
- A patent analysis with emphasis on emerging technologies and new developments in patent activity
- A discussion of ESG challenges and practices of the industry
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other market strategies
- Profiles of the leading companies, including Medtronic, Abbott, Boston Scientific Corp., F. Hoffmann-La Roche Ltd., and Koninklijke Philips N.V.
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Overview
Chapter 3 Market Dynamics
Chapter 4 Regulatory Landscape
Chapter 5 Emerging Technologies and Developments
Chapter 6 Market Segmentation Analysis
Chapter 7 Competitive Intelligence
Chapter 8 Sustainability in Smart Medical Devices Market: ESG Perspective
Chapter 9 Appendix
List of Tables
List of Figures
Companies Mentioned
- Abbott
- Biotronik
- Boston Scientific Corp.
- Connectedhealth
- Debiotech SA
- Dexcom Inc.
- F. Hoffmann-La Roche Ltd.
- Health Care Originals
- Insulet Corp.
- Koninklijke Philips N.V.
- Livanova PLC
- Medtronic
- Novo Nordisk A/S
- Omron Corp.
- Ypsomed
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 179 |
Published | July 2025 |
Forecast Period | 2025 - 2030 |
Estimated Market Value ( USD | $ 87.7 Billion |
Forecasted Market Value ( USD | $ 193.3 Billion |
Compound Annual Growth Rate | 17.1% |
Regions Covered | Global |
No. of Companies Mentioned | 15 |